The Baloch Liberation Army (BLA) asserted that its members killed at least seven Pakistani soldiers during a military ...

ISKP is weaker than the BLA in Balochistan. That could restrain it from attacking the latter in the immediate future.

Atara Biotherapeutics Inc (NASDAQ:ATRA) saw its stock jump 7% following the U.S. Food and Drug Administration’s acceptance of ...

The FDA has accepted the resubmitted BLA for tabelecleucel (tab-cel), intended for the treatment of Epstein-Barr virus ...

The Baloch Liberation Army (BLA) has claimed responsibility for a series of coordinated attacks on Pakistani security forces ...

The Opposition parties have nearly doubled the number of BLAs in the state to verify the additions and deletions made by the ...

Among reasons for the rejection, the agency cited a lack of US patient representation in the STARGLO trial assessing ...

Replimune Group, Inc – a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies – ...

Savara faces an FDA setback for Molbreevi, its aPAP treatment. Learn how the company plans to recover and file a new BLA by ...

Tabelecleucel, an allogeneic, EBV-specific T-cell immunotherapy, works by targeting and eliminating EBV-infected cells.

FDA issued Complete Response Letter Capricor plans to resubmit its BLA to include data from the ongoing Phase 3 HOPE-3 trial in Q3 2025 to continue pursuing the indication for the treatment of ...

Investing.com -- Atara Biotherapeutics Inc (NASDAQ: ATRA) stock surged 7% after the U.S. Food and Drug Administration (FDA) accepted the filing of its Biologics License Application (BLA) for ...